Literature DB >> 7592207

Acclimatization at high altitude in gradual and acute induction.

S S Purkayastha1, U S Ray, B S Arora, P C Chhabra, L Thakur, P Bandopadhyay, W Selvamurthy.   

Abstract

The study assessed physiological responses to induction to high altitude first to 3,500 m and then to 4,200 m and compared the time course of altitude acclimatization in two groups of male volunteers. The acutely inducted group was transported by aircraft (AI) to 3,500 m in 1 h, whereas the gradually inducted group was transported by road (RI) in 4 days. Baseline recordings of basal cardiovascular, respiratory, and blood gas variables were monitored at sea level as well as at 3,500 m on days 1, 3, 5, and 7. Blood gases were measured on day 10 also. After 15 days at 3,500 m, the subjects were inducted to 4,200 m by road, and measurements were repeated on days 1, 3, and 5, except blood gas variables, which were done on day 10 only. Acute mountain sickness symptoms were recorded throughout. The responses of RI were stable by day 3 of induction at 3,500 m, whereas it took 5 days for AI. Four days in transit for RI appear equivalent to 2 days at 3,500 m for AI. Acclimatization schedules of 3 and 5 days, respectively, for RI and AI are essential to avoid malacclimatization and/or high-altitude illness. Both groups took 3 days at 4,200 m to attain stability for achieving acclimatization.

Mesh:

Year:  1995        PMID: 7592207     DOI: 10.1152/jappl.1995.79.2.487

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  8 in total

Review 1.  Altitude sickness.

Authors:  David Murdoch
Journal:  BMJ Clin Evid       Date:  2010-03-18

Review 2.  Interventions for preventing high altitude illness: Part 1. Commonly-used classes of drugs.

Authors:  Víctor H Nieto Estrada; Daniel Molano Franco; Roger David Medina; Alejandro G Gonzalez Garay; Arturo J Martí-Carvajal; Ingrid Arevalo-Rodriguez
Journal:  Cochrane Database Syst Rev       Date:  2017-06-27

3.  Interventions for preventing high altitude illness: Part 3. Miscellaneous and non-pharmacological interventions.

Authors:  Daniel Molano Franco; Víctor H Nieto Estrada; Alejandro G Gonzalez Garay; Arturo J Martí-Carvajal; Ingrid Arevalo-Rodriguez
Journal:  Cochrane Database Syst Rev       Date:  2019-04-23

4.  Shilajit: A panacea for high-altitude problems.

Authors:  Harsahay Meena; H K Pandey; M C Arya; Zakwan Ahmed
Journal:  Int J Ayurveda Res       Date:  2010-01

Review 5.  Interventions for preventing high altitude illness: Part 2. Less commonly-used drugs.

Authors:  Alejandro Gonzalez Garay; Daniel Molano Franco; Víctor H Nieto Estrada; Arturo J Martí-Carvajal; Ingrid Arevalo-Rodriguez
Journal:  Cochrane Database Syst Rev       Date:  2018-03-12

6.  Correlation between blood pressure changes and AMS, sleeping quality and exercise upon high-altitude exposure in young Chinese men.

Authors:  Yang Liu; Ji-Hang Zhang; Xu-Bin Gao; Xiao-Jing Wu; Jie Yu; Jian-Fei Chen; Shi-Zhu Bian; Xiao-Han Ding; Lan Huang
Journal:  Mil Med Res       Date:  2014-08-26

7.  A specific objective supplemental factor in evaluating acute mountain sickness: ΔHR in combination with SaO2.

Authors:  Ming Li; Ji-Hang Zhang; Guo-Xi Zhao; Shi-Zhu Bian; Xu-Bin Gao; Xi Liu; Jie Yu; Jun-Qing Dong; Guo-Zhu Chen; Hong Wang; Lan Huang
Journal:  Mil Med Res       Date:  2015-10-26

8.  Causes of death and characteristics of non-survivors rescued during recreational mountain activities in Japan between 2011 and 2015: a retrospective analysis.

Authors:  Kazue Oshiro; Tomikazu Murakami
Journal:  BMJ Open       Date:  2022-02-03       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.